Tested Applications
| Positive WB detected in | A431 cells, human skin tissue, human spleen tissue |
| Positive IP detected in | A431 cells, HeLa cells |
| Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | A431 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:5000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11210-1-AP targets SUMF2 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1711 Product name: Recombinant human SUMF2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-221 aa of BC015600 Sequence: LPLLPLLSLLVGAWLKLGNGQATSMVQLQGGRFLMGTNSPDSRDGEGPVREATVKPFAIDIFPVTNKDFRDFVREKKYRTEAEMFGWSFVFEDFVSDELRNKATQPMKSVLWWLPVEKAFWRQPAGPGSGIRERLEHPVLHVSWNDARAYCAWRGKRLPTEEEWEFAARGGLKGQVYPWGNWFQPNRTNLWQGKFPKGDKAEDGFHGVSPVNAFPAQNNYG Predict reactive species |
| Full Name | sulfatase modifying factor 2 |
| Calculated Molecular Weight | 34 kDa |
| Observed Molecular Weight | 34 kDa |
| GenBank Accession Number | BC015600 |
| Gene Symbol | SUMF2 |
| Gene ID (NCBI) | 25870 |
| RRID | AB_2255511 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8NBJ7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SUMF2 antibody 11210-1-AP | Download protocol |
| IHC protocol for SUMF2 antibody 11210-1-AP | Download protocol |
| IP protocol for SUMF2 antibody 11210-1-AP | Download protocol |
| WB protocol for SUMF2 antibody 11210-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SUMF2 Polyclonal antibody (Cat# 11210-1-AP) has 4 citations published in Frontiers in Immunology, Scientific Reports, Discover Oncology, and International Journal of Clinical and Experimental Pathology. The research fields span bladder cancer prognostic modeling, prostate cancer transcriptome analysis, urothelial carcinoma biomarker prediction, and allergic inflammation. Applications cited include Western blot and immunohistochemistry in human and rat samples.
| Species | Application | Title |
|---|---|---|
Front Immunol Advancing bladder cancer management: development of a prognostic model and personalized therapy | ||
Sci Rep Exploring key genes and prognostic validation of prostate cancer through transcriptome-wide association study. | ||
Discov Oncol Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma | ||
Int J Clin Exp Pathol Downregulation of SUMF2 gene in ovalbumin-induced rat model of allergic inflammation. |















